Analysis of Hematological Indices and Splenectomy Rates in 2,130 Patients with Hemoglobin H Diseases or β-Thalassemia
Acta Haematologica · 2023
DOI: 10.1159/000533233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica, 2023. Verfasst von Yaoyun Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, 923rd Hospital of the People's Liberation Army, Nanning, China. Hauptthemen laut MEDLINE: beta-Thalassemia, alpha-Thalassemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Introduction
Splenomegaly and hypersplenism are common complications of thalassemia patients due to the excessive clearance of defective red blood cells from the spleen. To date, splenectomy has been considered one of the most effective treatments for splenomegaly, reducing clinical severity among thalassemia patients. Thus, we aim to investigate the differences in splenectomy rates and hematological indices among thalassemia patients with different genotypes.
Method
In this study, we analyzed the clinical data of thalassemia in 2,130 patients admitted to the 923rd Hospital of the People’s Liberation Army from January 2006 to December 2020, and the statistical software SPSS 26.0 was applied to analyze the data.
Result
Of the 2,130 patients with thalassemia, 265 patients underwent splenectomy. It was determined that significantly more patients with hemoglobin H (HbH) disease, a form of α-thalassemia, have undergone splenectomy than β-thalassemia patients (20% vs. 7%). Further, HbH disease patients were diagnosed at a significantly older age than β-thalassemia patients.
Conclusion
The greater probability of HbH disease patients undergoing splenectomy is likely influenced by multiple factors, including their lower dependency on transfusion, leading to high spleen compensatory stress on the spleen, and the destruction of defective erythrocytes. In contrast, β-thalassemia is clinically more severe and less tolerant of hemoglobin fluctuations. Based on these findings, clinicians are suggested to pay more attention to HbH disease patients as many of them are still under-transfused, which could lead to chronic hemolysis and more severe hepatosplenomegaly. These results might offer insight for improving the clinical management of patients with different types of thalassemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, 923rd Hospital of the People's Liberation Army, Nanning, China.
- Office of Clinical Trial Institute, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China, qinlangsmu@163.com.
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou, China, qinlangsmu@163.com.
- Guangdong Genetics Testing Engineering Research Center, Guangzhou, China, qinlangsmu@163.com.
- Clinical Laboratory, 923rd Hospital of the People's Liberation Army, Nanning, China.
Zitieren
APA
Li, Y., Zhang, Y., Qin, L., Shang, H., Li, P., Xiao, B., Ye, Y., Xu, X., Zhang, X., & Wang, L. (2023). Analysis of Hematological Indices and Splenectomy Rates in 2,130 Patients with Hemoglobin H Diseases or β-Thalassemia. Acta Haematologica. https://doi.org/10.1159/000533233
Vancouver
Li Y, Zhang Y, Qin L, Shang H, Li P, Xiao B, et al. Analysis of Hematological Indices and Splenectomy Rates in 2,130 Patients with Hemoglobin H Diseases or β-Thalassemia. Acta Haematologica. 2023. doi:10.1159/000533233
BibTeX
@article{Li2023,
author = {Li, Yaoyun and Zhang, Yaqing and Qin, Lang and Shang, Hangning and Li, Pingping and Xiao, Bin and Ye, Yuhua and Xu, Xiangmin and Zhang, Xinhua and Wang, Li},
title = {Analysis of Hematological Indices and Splenectomy Rates in 2,130 Patients with Hemoglobin H Diseases or β-Thalassemia},
journal = {Acta Haematologica},
year = {2023},
doi = {10.1159/000533233}
}
EUVIMED